From: Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage
Gender n (%) | Count, frequency (%) |
---|---|
Male | 31 (59.6) |
Female | 21 (40.4) |
Age average (years) ± standard deviation | |
 All patients | 70.8 ± 11.1 |
 Male | 74.1 ± 7.85 |
 Female | 66.2 ± 13.63 |
Clinical tumor stage, Â % | |
 I | 15 (28.8) |
 II | 16 (30.8) |
 III | 15 (28.8) |
 IV | 4 (7.7) |
 Unknown | 2 (3.8) |
Location, Â % | |
 Ascending right colon | 19 (36.5) |
 Transverse colon | 3 (5.8) |
 Descending left colon | 10 (19.2) |
 Cecum | 1 (1.9) |
 Rectum | 19 (36.5) |
 Unknown | 1 (1.9) |